These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 11087830)

  • 1. Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids.
    Schmidt EE; Taylor DS; Prigge JR; Barnett S; Capecchi MR
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13702-7. PubMed ID: 11087830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
    Jin C; McKeehan K; Wang F
    Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site- and time-specific gene targeting in the mouse.
    Metzger D; Chambon P
    Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cre expression in primary spermatocytes: a tool for genetic engineering of the germ line.
    Vidal F; Sage J; Cuzin F; Rassoulzadegan M
    Mol Reprod Dev; 1998 Nov; 51(3):274-80. PubMed ID: 9771647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2.
    Higashi AY; Ikawa T; Muramatsu M; Economides AN; Niwa A; Okuda T; Murphy AJ; Rojas J; Heike T; Nakahata T; Kawamoto H; Kita T; Yanagita M
    J Immunol; 2009 May; 182(9):5633-40. PubMed ID: 19380810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse.
    Schnütgen F; Doerflinger N; Calléja C; Wendling O; Chambon P; Ghyselinck NB
    Nat Biotechnol; 2003 May; 21(5):562-5. PubMed ID: 12665802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A transgenic mouse that targets the expression of Cre recombinase in hepatocyte].
    Wang YL; Cheng X; Cui F; Cheng J; Lü YX; Yang X
    Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):163-6. PubMed ID: 15059303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the fate of Sry-expressing cells using an in vivo Cre/loxP system.
    Ito M; Yokouchi K; Yoshida K; Kano K; Naito K; Miyazaki J; Tojo H
    Dev Growth Differ; 2006 Jan; 48(1):41-7. PubMed ID: 16466392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approach to cell lineage analysis in mammals using the Cre-loxP system.
    Sato M; Yasuoka Y; Kodama H; Watanabe T; Miyazaki JI; Kimura M
    Mol Reprod Dev; 2000 May; 56(1):34-44. PubMed ID: 10737965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
    Licht AH; Raab S; Hofmann U; Breier G
    Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cre-mediated chromosome loss in mice.
    Lewandoski M; Martin GR
    Nat Genet; 1997 Oct; 17(2):223-5. PubMed ID: 9326948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cre recombinase-mediated gene targeting of mesenchymal cells.
    Florin L; Alter H; Gröne HJ; Szabowski A; Schütz G; Angel P
    Genesis; 2004 Mar; 38(3):139-44. PubMed ID: 15048811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual renin gene targeting by Cre-mediated interchromosomal recombination.
    Matsusaka T; Kon V; Takaya J; Katori H; Chen X; Miyazaki J; Homma T; Fogo A; Ichikawa I
    Genomics; 2000 Mar; 64(2):127-31. PubMed ID: 10729219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertoli and granulosa cell-specific Cre recombinase activity in transgenic mice.
    Lécureuil C; Fontaine I; Crepieux P; Guillou F
    Genesis; 2002 Jul; 33(3):114-8. PubMed ID: 12124943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment of keratinocyte-specific Cre recombinase transgenic mice].
    Mao CM; Yang X; Cheng X; Lü YX; Zhou J; Huang CF
    Yi Chuan Xue Bao; 2003 May; 30(5):407-13. PubMed ID: 12924153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons.
    Gelman DM; Noaín D; Avale ME; Otero V; Low MJ; Rubinstein M
    Genesis; 2003 Aug; 36(4):196-202. PubMed ID: 12929090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flp recombinase transgenic mice of C57BL/6 strain for conditional gene targeting.
    Takeuchi T; Nomura T; Tsujita M; Suzuki M; Fuse T; Mori H; Mishina M
    Biochem Biophys Res Commun; 2002 May; 293(3):953-7. PubMed ID: 12051751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dorsal telencephalon-specific expression of Cre recombinase in PAC transgenic mice.
    Iwasato T; Nomura R; Ando R; Ikeda T; Tanaka M; Itohara S
    Genesis; 2004 Mar; 38(3):130-8. PubMed ID: 15048810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high-throughput screen identifying sequence and promiscuity characteristics of the loxP spacer region in Cre-mediated recombination.
    Missirlis PI; Smailus DE; Holt RA
    BMC Genomics; 2006 Apr; 7():73. PubMed ID: 16595017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The transgenic mice specifically express Cre recombinase in central nerve system].
    Sheng JP; Hou N; Cheng X; Yang X; Deng JX
    Yi Chuan Xue Bao; 2004 Dec; 31(12):1337-43. PubMed ID: 15633637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.